
Copart (CPRT) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Apr 2025Income Metrics
Revenue
1.2B
Gross Profit
552.3M
45.58%
Operating Income
451.5M
37.26%
Net Income
405.3M
33.45%
EPS (Diluted)
$0.42
Balance Sheet Metrics
Total Assets
9.7B
Total Liabilities
869.5M
Shareholders Equity
8.8B
Debt to Equity
0.10
Cash Flow Metrics
Operating Cash Flow
704.6M
Free Cash Flow
572.9M
Revenue & Profitability Trend
Copart Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 4.2B | 3.9B | 3.5B | 2.7B | 2.2B |
Cost of Goods Sold | 2.3B | 2.1B | 1.9B | 1.3B | 1.2B |
Gross Profit | 1.9B | 1.7B | 1.6B | 1.3B | 1.0B |
Gross Margin % | 45.0% | 44.9% | 45.9% | 49.9% | 45.7% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 335.2M | 250.4M | 231.2M | 206.7M | 191.7M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 335.2M | 250.4M | 231.2M | 206.7M | 191.7M |
Operating Income | 1.6B | 1.5B | 1.4B | 1.1B | 816.1M |
Operating Margin % | 37.1% | 38.4% | 39.3% | 42.2% | 37.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | 1.4M |
Interest Expense | - | - | 16.7M | 20.2M | 18.9M |
Other Non-Operating Income | -3.1M | 1.8M | -17.4M | 5.7M | 3.6M |
Pre-tax Income | 1.7B | 1.6B | 1.3B | 1.1B | 800.8M |
Income Tax | 352.3M | 316.6M | 250.8M | 185.4M | 100.9M |
Effective Tax Rate % | 20.5% | 20.4% | 18.7% | 16.5% | 12.6% |
Net Income | 1.4B | 1.2B | 1.1B | 936.5M | 699.9M |
Net Margin % | 32.2% | 32.0% | 31.1% | 34.8% | 31.7% |
Key Metrics | |||||
EBITDA | 1.8B | 1.6B | 1.5B | 1.3B | 924.0M |
EPS (Basic) | $1.42 | $1.30 | $1.15 | $0.99 | $0.75 |
EPS (Diluted) | $1.40 | $1.28 | $1.13 | $0.98 | $0.73 |
Basic Shares Outstanding | 960739000 | 953574000 | 949676000 | 945008000 | 932808000 |
Diluted Shares Outstanding | 960739000 | 953574000 | 949676000 | 945008000 | 932808000 |
Income Statement Trend
Copart Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 1.5B | 957.4M | 1.4B | 1.0B | 477.7M |
Short-term Investments | 1.9B | 1.4B | 0 | - | - |
Accounts Receivable | 173.7M | 157.1M | 137.2M | 97.2M | 94.3M |
Inventory | 43.6M | 40.0M | 58.8M | 45.0M | 20.1M |
Other Current Assets | 33.9M | 26.3M | 18.7M | 14.3M | 15.3M |
Total Current Assets | 4.4B | 3.3B | 2.2B | 1.7B | 963.8M |
Non-Current Assets | |||||
Property, Plant & Equipment | 116.3M | 108.1M | 116.3M | 119.5M | 118.5M |
Goodwill | 1.1B | 851.3M | 858.6M | 757.3M | 735.0M |
Intangible Assets | 74.1M | 62.7M | 54.7M | 45.9M | 47.8M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 129.4M | 65.8M | 47.7M | 41.8M | 40.1M |
Total Non-Current Assets | 4.0B | 3.5B | 3.1B | 2.9B | 2.5B |
Total Assets | 8.4B | 6.7B | 5.3B | 4.6B | 3.5B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 193.3M | 180.0M | 187.2M | 163.2M | 132.9M |
Short-term Debt | 21.3M | 21.5M | 21.8M | 22.5M | 25.6M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 628.6M | 492.8M | 440.9M | 421.0M | 356.0M |
Non-Current Liabilities | |||||
Long-term Debt | 97.4M | 99.0M | 97.7M | 495.6M | 493.0M |
Deferred Tax Liabilities | 93.7M | 89.5M | 80.1M | 64.0M | 71.7M |
Other Non-Current Liabilities | 24.5M | - | - | - | 430.0K |
Total Non-Current Liabilities | 250.6M | 257.7M | 242.4M | 611.9M | 609.7M |
Total Liabilities | 879.2M | 750.4M | 683.3M | 1.0B | 965.7M |
Equity | |||||
Common Stock | 96.0K | 96.0K | 96.0K | 24.0K | 24.0K |
Retained Earnings | 6.5B | 5.2B | 4.0B | 2.9B | 1.9B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 7.5B | 6.0B | 4.6B | 3.5B | 2.5B |
Key Metrics | |||||
Total Debt | 118.7M | 120.5M | 119.5M | 518.1M | 518.6M |
Working Capital | 3.8B | 2.8B | 1.8B | 1.3B | 607.7M |
Balance Sheet Composition
Copart Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 1.4B | 1.2B | 1.1B | 936.5M | 699.9M |
Depreciation & Amortization | 190.3M | 159.7M | 138.6M | 123.1M | 104.3M |
Stock-Based Compensation | 35.2M | 39.7M | 39.0M | 40.9M | 23.3M |
Working Capital Changes | -89.6M | -50.2M | -120.4M | -111.9M | 55.9M |
Operating Cash Flow | 1.5B | 1.4B | 1.2B | 980.7M | 906.5M |
Investing Activities | |||||
Capital Expenditures | -506.8M | -482.7M | -333.1M | -460.5M | -589.5M |
Acquisitions | 8.9M | -2.7M | -109.2M | -5.0M | -11.7M |
Investment Purchases | -4.1B | -1.4B | -374.9M | 0 | 0 |
Investment Sales | 3.6B | 0 | 374.9M | 0 | 0 |
Investing Cash Flow | -940.1M | -1.9B | -442.3M | -465.5M | -601.2M |
Financing Activities | |||||
Share Repurchases | - | - | - | 0 | 0 |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | -10.8M | -33.9M | -417.3M | -1.1M | -1.1M |
Financing Cash Flow | -28.2M | -28.1M | -420.4M | -7.3M | -107.3M |
Free Cash Flow | 961.6M | 847.6M | 839.2M | 527.9M | 325.9M |
Net Change in Cash | 529.1M | -523.3M | 301.6M | 507.9M | 197.9M |
Cash Flow Trend
Copart Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
31.18
Forward P/E
27.06
Price to Book
5.18
Price to Sales
9.92
PEG Ratio
6.24
Profitability Ratios
Profit Margin
32.21%
Operating Margin
37.27%
Return on Equity
18.44%
Return on Assets
12.02%
Financial Health
Current Ratio
8.16
Debt to Equity
1.15
Beta
1.04
Per Share Data
EPS (TTM)
$1.51
Book Value per Share
$9.08
Revenue per Share
$4.76
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
cprt | 45.5B | 31.18 | 5.18 | 18.44% | 32.21% | 1.15 |
Cintas | 86.4B | 48.81 | 18.43 | 40.27% | 17.53% | 56.67 |
Global Payments | 21.0B | 14.76 | 0.93 | 6.59% | 14.20% | 71.17 |
Rb Global | 19.9B | 52.98 | 3.77 | 7.39% | 9.68% | 76.45 |
Ul Solutions | 13.4B | 41.25 | 12.28 | 36.55% | 11.08% | 72.33 |
Rentokil Initial plc | 12.5B | 38.33 | 11.56 | 5.13% | 4.46% | 115.51 |
Financial data is updated regularly. All figures are in the company's reporting currency.